Google Research's TurboQuant memory-compression algorithm has raised concerns that demand for AI-related memory could weaken, but South Korean experts and analysts say the market reaction may be ...

As Large Language Models (LLMs) expand their context windows to process massive documents and intricate conversations, they encounter a brutal hardware reality known as the "Key-Value (KV) cache ...

How A.I.-Generated Videos Are Distorting Your Child’s YouTube Feed Experts caution that low-quality, A.I.-generated videos on YouTube geared toward children often feature conflicting information, lack ...

Forbes contributors publish independent expert analyses and insights. Gary Drenik is a writer covering AI, analytics and innovation. This voice experience is generated by AI. Learn more. This voice ...

The technical failure coincided with TikTok’s ownership transition, leading users to question whether videos criticizing ICE raids in Minnesota were being intentionally censored. TikTok is currently ...

Elon Musk's social network X (formerly known as Twitter) last night released some of the code and architecture of its overhauled social recommendation algorithm under a permissive, enterprise-friendly ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

A2Z/ ├── Problems/ # Solved problems organized by difficulty │ ├── Easy/ # Easy level problems │ ├── Medium/ # Medium level problems │ └── Hard/ # Hard level problems │ ├── DataStructures/ # Core data ...

One day in November, a product strategist we’ll call Michelle (not her real name), logged into her LinkedIn account and switched her gender to male. She also changed her name to Michael, she told ...

Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to set their weight loss assets apart in an increasingly crowded field as ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...